ArticleHuman immunology
Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.
Daniel G Camblor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
pooled itcites it